Organisation paid for research Program year 2025 Source: CMS Open Payments

Methodist Research Institute

Neither a doctor nor a teaching hospital

Research payments

$2,773,240

118 payments

Through program year 2025, Methodist Research Institute is reported as receiving $2,773,240 in research payments, across 118 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$196,925	15
2024	Research	$396,005	16
2023	Research	$296,186	15
2022	Research	$477,644	19
2021	Research	$604,158	23
2020	Research	$706,840	18
2019	Research	$95,482	12

Breakdown

Who paid Research payments · program years 2019–2025

Boston Scientific Corporation $2,494,532 101 payments
Medtronic, Inc. $173,685 3 payments
E.R. Squibb & Sons, L.L.C. $84,147 2 payments
Actelion Pharmaceuticals, Ltd $12,820 8 payments
AstraZeneca Pharmaceuticals LP $5,056 1 payment
Abbott Laboratories $3,000 3 payments

Studies the money was for Research payments · program years 2019–2025

Acurate Ide $2,493,532 100 payments
Spyral Affirm $173,685 3 payments
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with Heart Failure and Impaired Systoli $75,606 1 payment
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with Heart Failure and $8,541 1 payment
Opus - Ac-055-503 $8,200 5 payments
A Multinational Randomised Double Blind Placebo Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death Myocardial Infarction or Stroke in Patients with Type 2 Diabetes $5,056 1 payment
Ac-055-205 $4,620 3 payments
MOMENTUM 3 CAP Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 Continued Access Protocol $1,000 1 payment
Untouched $1,000 1 payment
Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3 Continued Access Protocol $1,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.